About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Gene Delivery System Shows Promise in Vision Loss Prevention

by Bidita Debnath on May 11, 2017 at 11:48 PM
Font : A-A+

 New Gene Delivery System Shows Promise in Vision Loss Prevention

Researchers have developed gene- carrying nanoparticles that home in on target cells and prevent vision loss in animal models of an inherited eye disease which is also one of the most common causes of blindness in kids.

Though this research, published in the journal Molecular Therapy - Nucleic Acids, focused on the form of the disease called Leber congenital amaurosis 2, or LCA2, the scientists and engineers involved in the study believe the technology holds promise for other forms of LCA as well as other inherited diseases that lead to severe vision loss or blindness.

Advertisement


"We believe this technology can deliver almost any type of gene to tackle inherited visual disorders," said lead researcher Zheng-Rong Lu, Professor at Case Western Reserve University in Cleveland, Ohio, US.

Those with LAC2 carry a mutated RPE65 gene and suffer from profound vision loss from birth.

The mutated gene fails to produce RPE65 protein in the retinal pigment epithelium (RPE), a cell layer critical for protecting photoreceptors (rods and cones).
Advertisement

The protein is an essential constituent of the visual cycle that converts light to electrical signals to the brain.

Lu and colleagues designed a lipid-based nanoparticle called ECO to deliver healthy RPE65 genes to RPE cells.

"The promise of this technology is it localises the drug to the photoreceptor cells, sparing the liver and kidney from exposure," Krzysztof Palczewski from the Case Western Reserve School of Medicine said.

Following injection into the retina of mice, the researchers could see fluorescent green concentrating in RPE cells.

Testing showed a significant increase in light-induced electrical activity from the eyes to the brain, indicating the rods and cones were operating as they should in the visual cycle.

The therapeutic effect lasted 120 days in treated mice and no improvements were observed in untreated mice.

"This work is important beyond one disease," Palczewski said.

"The loss of photoreceptor cells affects virtually all of us," Palczewski noted.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Astigmatism Vision Weaver Syndrome Pink Eye Symptom Evaluation Intracranial Hypertension Coloboma Endophthalmitis Orbital Cellulitis 

Most Popular on Medindia

Blood Donation - Recipients Color Blindness Calculator Calculate Ideal Weight for Infants Sinopril (2mg) (Lacidipine) Vent Forte (Theophylline) Drug Interaction Checker Daily Calorie Requirements A-Z Drug Brands in India The Essence of Yoga Loram (2 mg) (Lorazepam)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

New Gene Delivery System Shows Promise in Vision Loss Prevention Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests